| Description | Cadonilimab (AK104) is a humanized antibody engineered from the IgG1 scaffold and targets PD1/CTLA4. It is utilized in the research of metastatic cervical cancer [1] [2]. |
| molecular weight | N/A |
| CAS | 2394841-59-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |